Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis

Veterinary Parasitology

Volumn 139, Issue 1-3, 2006, Pages 37-46

  Rodrigues, Flávio H ^a   Afonso Cardoso, Sandra R ^a   Gomes, Márcio A B ^a   Beletti, Marcelo E ^a   Rocha, Ademir ^a   Guimarães, Aparecida H B ^a   Candeloro, Ignes ^a   de Souza, Maria A ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Antileishmanial agents; Leishmania amazonensis; Leishmaniasis

Indexed keywords

IMIDOCARB; IMIDOCARB DIPROPIONATE; IMMUNOGLOBULIN G; LEVAMISOLE;

ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; EXPERIMENTAL INFECTION; FOOT PAD; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; LEISHMANIA; LYMPH NODE; MACROPHAGE; MALE; MEGAKARYOCYTE; MICROPHOTOGRAPHY; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE LOCALIZATION; PROMASTIGOTE; SPLEEN; SWELLING; TONOPLAST;

ANIMALS; ANTIPROTOZOAL AGENTS; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMIDOCARB; LEISHMANIA; LEISHMANIASIS; LEVAMISOLE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; PARASITIC SENSITIVITY TESTS;

ANIMALIA; LEISHMANIA AMAZONENSIS;

EID: 33646853869     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.02.032     Document Type: Article

References (32)

1. Abreu-Silva A.L., Calabrese K.S., Cupolilo S.M.N., Cardoso F.O., Souza C.S.F., and Gonçalves da Costa S.C. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Vet. Parasitol. 121 (2004) 179-187
2. Alrajhi A.A., Ibrahim E.A., De Vol E.B., Khairat M., Faris R.M., and Maguire J.H. Fluconazol for the treatment of cutaneous leishmaniasis caused by Leishmania major. N. Engl. J. Med. 346 (2002) 891-895
3. Antoine J., Prina E., Lang T., and Courret N. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol. 7 10 (1998) 301-392
4. Bahamdan K.A., Tallab T.M., Johargi H., Nourad M.M., Ibrahim K., El Sherbini A.H., Karkashan E., Khare A.K., and Nauri M.M. Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. Int. J. Dermatol. 36 (1997) 59-60
5. Basselin L., Badet-Denisot M., Lawrence F., and Robert-Gero M. Effects of pentamidine on polyamine level and biosynthesis in wild-type, pentamidine-treated, and pentamidine-resistant Leishmania. Exp. Parasitol. 85 (1997) 274-282
6. Becker I., Volkow P., Velasco-Castrejon O., Salaiza-Suazo N., Berzunza-Cruz M., Dominguez J.S., Moralez-Vargas A., Ruiz-Remigio A., and Perez-MontFort R. The efficacy of pentamidine combined with alluporinol and immunotherapy for treatment of patients with diffuse cutaneous leishmaniasis. Parasitol. Res. 85 (1999) 165-170
7. Beveridge E. Babesicidal effect of basically substituted carbanilides. II Imidocarb in rats and mice: toxicity and activity against Babesia rodhaini. Res. Vet. Sci 10 (1969) 534-539
8. Bozic F., Bilic V., and Valpotic I. Levamisole mucosal adjuvant activity for a live attenuated Escherichia coli oral vaccine in weaned pigs. J. Vet. Pharmacol. Therap. 26 (2003) 225-231
9. Coldham N.G., Moore A.S., Sivapathasundaram S., and Sauer M.J. Imidocarb depletion from cattle liver and mechanism of retention in isolated bovine hepatocytes. Analyst 119 12 (1994) 2549-2552
10. Croft S.L., and Coombs G.H. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19 18 (2003) 502-508
11. Donkor I.O., Assefa H., Rattendi D., Lanne S., Vargas M., Goldberg B., and Bacchi C. Trypanocidal activity of dicationic compounds related to pentamidine. Eur. J. Med. Chem. 36 (2001) 531-538
12. Dube A., Singh N., Sundar S., and Singh N. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in vitro and in vivo experimental models. Parasitol. Res. 96 (2005) 216-223
13. Fauraty-Gambarelli F., Piarroux R., Deniau M., Giusiano B., Marty P., Michael G., Faugere B., and Dumon H. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41 (1997) 827-830
14. Grimaldi G.F., Moriearty P.L., and Hoff R. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections. Clin. Exp. Immunol. 41 (1980) 237-242
15. Grossage S.M., Rogers M.E., and Bates P.A. Two separate growth phases during the development of Leishmania in sand flies: implications for understanding the life cycle. Int. J. Parasitol. 33 (2003) 1027-1034
16. Herwaldt B.L., and Berman J.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostan) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46 (1992) 296-306
17. Igarashi K., and Kashiwagi K. Polyamines: mysterious modulator of cellular functions. Biochem. Biophys. Res. Commun. 271 (2000) 559-564
18. Jin H., Li Y., Ma Z., Zhang F., Xie Q., Gu D., and Wang B. Effect of chemical adjuvants on DNA vaccination. Vaccine 22 (2004) 2925-2935
19. Katayama T., Hayashi Y., Nagahira K., Konishi K., Yamaichi K., and Oikawa S. Imidocarb, a potent anti-protozoan drug, up-regulates interleukin-10 production by murine macrophages. Biochem. Biophys. Res. Commun. 309 (2003) 414-418
20. Leandro C., and Campino L. Leishmaniasis: efflux pumps and chemoresistance. Int. J. Antimicrob. Agents 22 (2003) 352-357
21. Lenzi H.L., Lenzi J.A., Rosman F.C., Pelajo-Machado M., Mota E.M., Panasco M.S., and Oliveira D.N. Extramedullary hematopoiesis in murine schistosomiasis mansoni. Mem. Inst. Oswaldo Cruz 90 (1995) 169-177
22. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
23. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 11 (2002) 549-555
24. Miles S.A., Conrad S.M., Alves R.G., Jerônimo S.M.B., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201 5 (2005) 747-754
25. Moore A.S., Coldham N.G., and Sauer M.J. A cellular mechanism for imidocarb retention in edible bovine tissues. Toxicol. Lett. 87 (1996) 61-68
26. Nathan H.C., Soto K.V.M., Moreira R., Chunosoff L., Hutner S.H., and Bacchi C.J. Curative effects of the antipiroplasms amicarbalide and imidocarb on Trypanosoma brucei infection in mice. J. Protozool. 26 4 (1979) 657-660
27. Naylor P.H., and Hadden J.W. T cell targeted enhancement yields effective T cell adjuvants. Int. Immunopharmacol. 3 (2003) 1205-1215
28. Oliveira C.I., Teixeira M.J., Gomes R., Barral A., and Brodskyn C. Animal model for infectious diseases caused by parasites: Leishmaniasis. Drug Discov. Today: Dis. Model 1 (2004) 81-86
29. Rezai H.R., Behbehani A.B., Gettner S., and Ardehali S. Effect of levamisole on the course of experimental leishmaniasis in guinea-pigs and mice: haematological and immunological findings. Ann. Top. Med. Parasitol. 82 3 (1988) 243-249
30. Singh S., and Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J. Infect. Chemother. 10 (2004) 307-315
31. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6 (2001) 849-854
32. Teti D., Visalli M., and Mcnair H. Analysis of polyamines as markers of pathophysiological conditions. J. Chromatogr. B 781 (2002) 107-149